Nippon Soda Co., Ltd.
Medium-Term Management Plan ‘Sparkling with Science. Stage III’ Review
A detailed review of Nippon Soda's medium-term management plan 'Sparkling with Science. Stage III' and future outlook. It highlights progress in research and development, new businesses, and investment strategies, along with priority initiatives moving forward.
Key Figures
- Research and Development Expenses: 20.1 billion yen (FY2023)
- Investment Amount: 35 billion yen (Target for FY2029)
- Increase Rate of R&D Expenses: Not specified
AI要約
Business Strategy and Progress
Nippon Soda has focused on expanding research and development investments and creating new businesses based on the medium-term management plan 'Sparkling with Science. Stage III.' To achieve KPIs for fiscal 2029, R&D expenses were increased to 20.1 billion yen, promoting expansion in pharmaceuticals and environmental-related businesses. Alongside strengthening existing businesses, the company is actively pursuing new business launches and M&A activities. Going forward, it aims for sustainable growth by centering on R&D and business alliances.
Future Outlook and Key Initiatives
The company has articulated a long-term vision beyond 2030, continuing to accelerate R&D and expand new businesses. Particular emphasis is placed on strengthening competitiveness in pharmaceuticals and environmental solutions, with flexible capital policies and investment strategies. R&D investment is targeted at 35 billion yen, promoting the adoption of next-generation technologies utilizing AI and IoT. Furthermore, through M&A and business partnerships, the company seeks to expand globally and diversify its operations, demonstrating a commitment to achieving sustainable growth.
Nippon Soda Co., Ltd.
Company overview · Stock price · Financial data · All IR